| human | Q5 |
| P269 | IdRef ID | 19740345X |
| P6634 | LinkedIn personal profile ID | amélie-beaudet-11847013 |
| P496 | ORCID iD | 0000-0003-0535-672X |
| P214 | VIAF ID | 305970290 |
| P512 | academic degree | doctorate in France | Q3033550 |
| P27 | country of citizenship | France | Q142 |
| P184 | doctoral advisor | José Braga | Q3186211 |
| François Bon | Q45826301 | ||
| Roberto Macchiarelli | Q65120498 | ||
| P69 | educated at | Toulouse III University - Paul-Sabatier | Q1273188 |
| P108 | employer | University of the Witwatersrand | Q534643 |
| P734 | family name | Beaudet | Q37313964 |
| Beaudet | Q37313964 | ||
| Beaudet | Q37313964 | ||
| P735 | given name | Amélie | Q2652203 |
| Amélie | Q2652203 | ||
| P1412 | languages spoken, written or signed | French | Q150 |
| English | Q1860 | ||
| P106 | occupation | researcher | Q1650915 |
| paleobiologist | Q16037036 | ||
| P21 | sex or gender | female | Q6581072 |
| Q53813732 | Burden of Non-Adherence To Type 1 Diabetes Mellitus Therapeutic Guidelines In France. |
| Q82371964 | Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China |
| Q46127637 | Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK. |
| Q59789980 | Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA) |
| Q55286186 | Elicitation of health state utilities associated with the mode of administration of drugs acting on the prostacyclin pathway in pulmonary arterial hypertension. |
| Q98157809 | Evidence synthesis in pulmonary arterial hypertension: a systematic review and critical appraisal |
| Q89955098 | Identification of a pulmonary arterial hypertension (PAH) patient cohort and study of its burden of illness in Programme de Médicalisation des Systèmes d'information (PMSI) |
| Q53915823 | Progression of Physiological Parameters Over Time in Type 1 Diabetes Mellitus Patients in France. |
| Q38223529 | Review of utility values for economic modeling in type 2 diabetes. |
Search more.